Nominate Australia's biotech leaders for this year's Industry Excellence Awards
05 August, 2014Who do you think are the industry's high achievers? The annual Industry Excellence Awards celebrate the individuals and organisations that have made a significant contribution to the biotechnology industry and, through their leadership, continue to make a difference to the growth of the bio-economy. The recipients of these prestigious awards are at the forefront of thriving biotech, innovation and healthcare sectors in Australia.
ResMed Q4 net grows 20% despite weak Americas sales
05 August, 2014 by Dylan Bushell-EmblingResMed (ASX:RMD) has reported a 20% growth in profit but flat revenue for the fourth quarter, and reported the results of a successful study into using NPPH to treat advanced COPD.
Cochlear net grows 32% thanks to new products
05 August, 2014 by Dylan Bushell-EmblingCochlear (ASX:COH) grew its 2H14 profit by 32% and sales by 28% as the company launched new additions to each of its product categories.
US doctors using Osprey's AVERT in PAD
04 August, 2014 by Dylan Bushell-EmblingUS physicians have identified a potential new market for Osprey's AVERT system, which is designed to help protect the kidneys from toxic dyes used in X-ray imaging.
Pharmaxis sues NovaQuest over financing deal breach
04 August, 2014 by Dylan Bushell-EmblingPharmaxis (ASX:PXS) is taking NovaQuest to court, seeking a reinstatement of the US$40 million financing arrangement covering commercialisation of Bronchitol in the EU and US.
Iluvien approved in Norway and Denmark: pSivida
01 August, 2014 by Dylan Bushell-Embling and Lauren DavispSivida (ASX:PVA) revealed its licensee Alimera has won approval in Norway and Denmark, and reimbursement in Portugal, for diabetic macular oedema treatment Iluvien.
International congress for plant biotechnology coming to Melbourne in August
31 July, 2014Melbourne is about to host the next International Association for Plant Biotechnology (IAPB) Congress 2014.
Admedus lifts stake in vaccines unit to 66%
30 July, 2014 by Dylan Bushell-EmblingAdmedus (ASX:AHZ) has invested to increase its stake in vaccines unit Admedus Vaccines to 66.3%, and has reported sales of $7.8m for the June quarter.
ResMed wins sales ban against APEX in Germany
29 July, 2014 by Dylan Bushell-EmblingA German court has issued an injunction prohibiting Taiwan's APEX Medical from local sales of two face masks found to infringe on ResMed (ASX:RMD) patents.
Wikibomb to boost online role models for women scientists
29 July, 2014The Australian Academy of Science is holding the Women of Science Wikibomb as part of the coming National Science Week activities, and interested individuals are invited to help create and improve the Wikipedia pages of Australian female scientists.
Report shows Employee Share Schemes could boost economy
24 July, 2014A new report shows that a reversal of the 2009 Employee Share Scheme (ESS) laws would potentially boost the Australian economy by more than $1.4 billion in the long term.
Win for ResMed as ITC upholds import ban
22 July, 2014 by Dylan Bushell-EmblingThe US ITC has upheld an import ban on a device sold by Taiwan's APEX found to infringe on ResMed patents, even after a redesign.
PolyNovo gets CE Mark for NovoPore dressing
22 July, 2014 by Dylan Bushell-EmblingCalazada's (ASX:CZD) PolyNovo now has approval to market its NovoPore TNP dressing in the majority of its addressable market, after securing approvals in Europe.
Perth's Orthocell raises $8m in oversubscribed IPO
22 July, 2014 by Dylan Bushell-EmblingOrthocell has completed an IPO, raising $8m to help market and prepare approvals for its regenerative medicine products, while paving the way for an ASX listing in August.
New one-stop portal for government's business support
22 July, 2014As part of changes to business support made in the May federal Budget, the Department of Industry's services will be accessed via a new one-stop web portal called the Single Business Service.
